Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

AXIM
AXIM BIOTECHNOLOGIES INC
stock OTC

EOD
Jul 30, 2026
0.0031USD-0.766%(0.0000)59,110
Pre-market
0.00USD-100.000%(0.00)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 21, 2021
09:00AM EST  CDC Publishes AXIM Biotechnologies-Sponsored Study on   GlobeNewswire Inc
Nov 18, 2021
11:16AM EST  AXIM Biotechnologies Applauds FDA's Recent COVID-19 Test Policies   GlobeNewswire Inc
Nov 16, 2021
09:00AM EST  AXIM Biotechnologies, Inc (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting COVID-19 diagnostics and oncological research, announced today that it has partnered with Arizona State University to develop a COVID-19 Correlate of Protection using AXIMs rapid neutralizing antibody test.   GlobeNewswire Inc
Nov 9, 2021
09:00AM EST  AXIM Biotechnologies, Inc (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting COVID-19 diagnostics and oncological research, today announced their publication in the Journal of Clinical Virology describing the development of a rapid test to measure levels of neutralizing antibodies to SARS-CoV-2.   GlobeNewswire Inc
Nov 2, 2021
09:00AM EDT  AXIM Biotechnologies Appoints Clinical Research and DED Expert Dr.   GlobeNewswire Inc
Oct 20, 2021
09:00AM EDT  AXIM Biotechnologies Appoints Dry Eye Disease Expert and   GlobeNewswire Inc
Oct 12, 2021
09:00AM EDT  AXIM Biotechnologies, Inc (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced the development of the second generation version of its Rapid Neutralizing Antibody Test for COVID-19.   GlobeNewswire Inc
Oct 11, 2021
09:00AM EDT  AXIM Biotechnologies Appoints Leading US Ophthalmic   GlobeNewswire Inc
Oct 5, 2021
09:00AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, or the Company), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced it has appointed Laura M Periman, MD to its recently established Medical Advisory Board. In this role, she joins the Boards Chairman Dr. Joseph Tauber as its second member.   GlobeNewswire Inc
Sep 21, 2021
09:00AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, or the Company), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced that it has appointed Joseph Tauber, MD as Chief Medical Officer and Chairman of its Medical Advisory Board.   GlobeNewswire Inc
Sep 15, 2021
09:27AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), a leader in the development of diagnostic testing for COVID-19, dry eye disease (DED) and Cancer, today announced that it has appointed Jeffrey A. Busby to Senior Vice President Business Development.   GlobeNewswire Inc
Aug 30, 2021
09:00AM EDT  AXIM Biotechnologies Manufacturing   GlobeNewswire Inc
Aug 3, 2021
09:00AM EDT  AXIM Biotechnologies to Acquire Technology Including   GlobeNewswire Inc
May 5, 2021
08:12AM EDT  AXIM Biotechnologies Manufacturing   GlobeNewswire Inc
May 3, 2021
09:00AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announced today a new ELISA test that measures levels of neutralizing antibodies against six common variants of SARS-CoV-2 virus. The Company has also filed for patent protection for the diagnostic test.   GlobeNewswire Inc
Mar 24, 2021
09:00AM EDT  AXIM Biotechnologies Manufacturing   GlobeNewswire Inc
Mar 8, 2021
09:00AM EST  AXIM Biotechnologies Successfully Completes   GlobeNewswire Inc
Feb 3, 2021
09:00AM EST  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the initiation of clinical trials for ImmunoPass, the Companys rapid point-of-care test that semi-quantitatively measures levels of neutralizing antibodies to COVID-19.   GlobeNewswire Inc
Jan 11, 2021
09:00AM EST  AXIM Biotechnologies Releases Preprint Manuscript   GlobeNewswire Inc
Dec 15, 2020
09:00AM EST  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has filed an amended Emergency Use Authorization (EUA) application with the US Food and Drug Administration (FDA).   GlobeNewswire Inc
Dec 14, 2020
09:00AM EST  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the Companys CEO John W. Huemoeller II will be presenting at the 13th Annual LD Micro Main Event investor conference on Monday, December 14, 2020, at 11:00 a.m. PST/2:00 p.m. EST.   GlobeNewswire Inc
Dec 3, 2020
09:00AM EST  AXIM Biotechnologies Develops ELISA-Based Neutralizing   GlobeNewswire Inc
Nov 10, 2020
09:00AM EST  AXIM Biotechnologies Applauds Vaccine Producers,   GlobeNewswire Inc
Oct 28, 2020
09:00AM EDT  AXIMBiotechnologies, Inc.(OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research,announced today that it has issued a letter to its shareholders providing commentary on the Companys recent announcements and upcoming plans.   GlobeNewswire Inc
Oct 6, 2020
09:01AM EDT  Medical Marijuana, Inc. Investment Company AXIM   GlobeNewswire Inc
Sep 30, 2020
09:11AM EDT  AXIM Biotechnologies, Inc.(OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has filed a provisional patent for a recombinant virus binding protein (VBP) for SARS-CoV-2, the coronavirus responsible for the current COVID-19 pandemic, and is now manufacturing the VBP.   GlobeNewswire Inc
Sep 29, 2020
09:00AM EDT  AXIM Biotechnologies, Inc.(OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it has filed a provisional patent for a first-in-class face mask that captures and deactivates SARS-CoV-2, the coronavirus responsible for the ongoing COVID-19 pandemic.   GlobeNewswire Inc
Sep 22, 2020
09:00AM EDT  AXIM Biotechnologies Receives Notice of U.S. Patent   GlobeNewswire Inc
Sep 16, 2020
09:00AM EDT  AXIM Biotechnologies Files Emergency Use Authorization   GlobeNewswire Inc
Sep 1, 2020
06:03PM EDT  Cannabis Stock Gainers And Losers From September 1, 2020   Benzinga
Aug 24, 2020
06:23AM EDT  AXIM Biotechnologies Signs an Agreement with Empowered Diagnostics to Produce AXIM's COVID-19 Rapid Test   Benzinga
06:20AM EDT  AXIM Biotechnologies Signs Exclusive Licensing,   GlobeNewswire Inc
Aug 11, 2020
09:00AM EDT  Sapphire Biotech, Subsidiary of AXIM Biotechnologies,   GlobeNewswire Inc
Aug 5, 2020
08:30PM EDT  Cannabis Stock Gainers And Losers From August 5, 2020   Benzinga
09:00AM EDT  AXIM Biotechnologies Applies for FDA Emergency Use   GlobeNewswire Inc
Jul 23, 2020
09:01AM EDT  AXIM Biotechnologies Releases Rapid NeuCovix Test Results Showing Strong Agreement With Coronavirus-Based Neutralization Tests   Benzinga
09:00AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and COVID-19 research, announces the completion of a study highlighting the performance of NeuCovix, AXIMs rapid test to measure levels of neutralizing anti-COVID-19 antibodies.   GlobeNewswire Inc
Jul 21, 2020
09:00AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has welcomed Former Secretary of Veterans Affairs Peter O'Rourke to the Companys Board of Directors.   GlobeNewswire Inc
09:00AM EDT  Medical Marijuana, Inc. Investment Company AXIM   GlobeNewswire Inc
Jul 16, 2020
04:58PM EDT  Cannabis Stock Gainers And Losers From July 16, 2020   Benzinga
Jul 15, 2020
08:30AM EDT  AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.   GlobeNewswire Inc
Jul 13, 2020
05:11PM EDT  Cannabis Stock Gainers And Losers From July 13, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC